美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Dorsey Wright Healthcare Momentum ETF

61.14

-0.8805-1.42%

盤後：61.170.0281+0.05%19:30 EDT

成交量：2.15萬

成交額：131.52萬

市值：2.87億

市盈率：20.00

高：62.20

開：62.20

低：60.99

收：62.02

52周最高：64.10

52周最低：40.28

股本：470.00萬

流通股本：470.00萬

量比：0.44

換手率：0.46%

股息：1.53

股息率：2.50%

每股收益(TTM):3.06

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

透景生命：申報6項醫療器械註冊獲上海市藥監局受理

山東省寧陽縣市場監管局開展驗光儀專項檢查

中国质量新闻网

一批國家標準發布！涉及自動駕駛系統安全、人工智能醫療器械質量要求等

黑龙江发布

醫療器械板塊震盪反彈寶萊特20cm漲停

板塊普漲之際十隻量化評分強勁的大盤醫療保健股

Tango因季度虧損額超出預期而股價下跌

Truist因Revolution Medicines在肺癌研發管線方面的潛力而上調其目標價

市值超4800億元的藥企股價漲逾4%: 這款「癌王」突破療法要來中國了

港股異動 | 百濟神州(06160)早盤升逾4% 與Revolution Medicines達成臨床合作將加快RAS賽道開發進展

中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化

中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化

百濟神州與Revolution Medicines達成臨床開發及區域商業化合作

百濟神州與Revolution Medicines宣佈合作；甘李藥業宣佈減肥新藥海外BD | 醫藥早參

每日经济新闻

百濟神州獲Revolution Medicines四大資產在選定亞洲市場的獨家授權

百濟神州與Revolution Medicines合作：里程碑付款與分級版税權益

上海：支持企業研發的創新藥、現代中藥和高端醫療器械全球註冊認證並在當地實現銷售

上海市藥品監督管理局批准註冊28項醫療器械產品

葵花葯業投資成立醫藥公司

華東醫藥(000963.SZ)子公司醫療器械獲得歐盟MDR CE認證

浙江推進醫療器械臨床創新成果轉化

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/PTH/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":61.1419,"timestamp":1789761600000,"preClose":62.0224,"halted":0,"volume":21465,"hourTrading":{"tag":"盘后","latestPrice":61.17,"preClose":61.1419,"latestTime":"19:30 EDT","volume":14,"amount":854.6914,"timestamp":1789774205841,"change":0.0281,"changeRate":0.00046,"amplitude":0},"delay":0,"changeRate":-0.014196483850995735,"floatShares":4700000,"shares":4700000,"eps":3.057033,"marketStatus":"休市中","change":-0.8805,"latestTime":"09-18 16:00:00 EDT","open":62.1967,"high":62.1967,"low":60.985,"amount":1315202.557005,"amplitude":0.019536,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.0224,"sharesOutstanding":2480000,"nav":61.98522,"aum":293809942.8,"dividendRate":0.024953,"bidAskSpread":0.001708,"preHourTrading":{"tag":"盘前","latestPrice":62.0224,"preClose":62.0224,"latestTime":"04:00 EDT","volume":1,"amount":62.0224,"timestamp":1789718420500,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":61.17,"preClose":61.1419,"latestTime":"19:30 EDT","volume":14,"amount":854.6914,"timestamp":1789774205841,"change":0.0281,"changeRate":0.00046,"amplitude":0},"volumeRatio":0.44234201260746575,"impliedVol":0.0872,"impliedVolPercentile":0.243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4700000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.44234201260746575,"shares":4700000,"dividePrice":1.5257,"high":62.1967,"amplitude":0.019536,"preClose":62.0224,"low":60.985,"week52Low":40.28,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":61.1419,"eps":3.057033,"divideRate":0.024953,"volume":21465,"delay":0,"ttmEps":3.057033,"open":62.1967,"prevYearClose":49.701,"prevWeekClose":60.7692,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":60.7692,"twentyDayClose":62.111,"sixtyDayClose":55.6532},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658392779","title":"透景生命：申報6項醫療器械註冊獲上海市藥監局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2658392779","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658392779?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 16:25","pubTimestamp":1786523152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","LGHT","GDOC","AGNG","MDEV","PTH","RSPH","MEDX","HART","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658091927","title":"山東省寧陽縣市場監管局開展驗光儀專項檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2658091927","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658091927?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 16:23","pubTimestamp":1786522980,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 8月11日，山东省宁阳县市场监管局执法人员对辖区眼镜经营门店开展医疗器械专项检查。本次检查聚焦电脑验光仪等验光诊疗设备，执法人员现场核对设备医疗器械注册证、定期计量检定记录，核查设备台账、使用维护记录是否完整规范，仔细查验仪器标识、出厂资料是否齐全有效。执法人员向经营商户宣讲医疗器械经营、计量器具管理相关法规，督促经营者落实主体责任，定期校验验光设备，杜绝不合格验光仪器投入使用，精准保障群众配镜验光数据准确，切实守护群众用眼健康安全。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-12/doc-inimzytn5280865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IEIH","BK1583","RSPH","LGHT","BK1574","AGNG","GDOC","HART","PTH","MDEV","MEDX","09996","LNGR","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658924259","title":"一批國家標準發布！涉及自動駕駛系統安全、人工智能醫療器械質量要求等","url":"https://stock-news.laohu8.com/highlight/detail?id=2658924259","media":"黑龙江发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658924259?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 14:56","pubTimestamp":1786517760,"startTime":"0","endTime":"0","summary":"转自：黑龙江发布近日，市场监管总局批准发布338项重要国家标准。其中，强制性国家标准15项，推荐性国家标准323项，涉及高新技术领域、传统产业、安全生产、百姓生活等方面。该批标准发布后将在推动产业高质量发展、提升人民群众生活品质、保障生命财产安全等方面发挥重要作用。在高新技术领域方面发布人工智能医疗器械质量要求和评价术语国家标准，促进建立人工智能医疗器械国家标准体系，为产品的开发、测试及质量控制提供依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-12/doc-inimzumm6916697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","QTOC","MDEV","AIBU","09996","FWD","MEDX","AIQU","NEWZ","GDOC","161631","DRIV","HART","MFIG","IQM","DQJN","AIFD","LCLG","PBOT","AGNG","CWC","LNGR","HAIL","QSWN","WPAI","TECY","AQGX","GK","ROBT","MVPS","CHAT","QID","RSPH","CARZ","XT","AGIX","LGHT","CPNQ","OGIG","PTH","NBDS","FDIF","VUSE","MOTO","QQA","IEIH","ARTY","IDRV","FAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658254579","title":"醫療器械板塊震盪反彈 寶萊特20cm漲停","url":"https://stock-news.laohu8.com/highlight/detail?id=2658254579","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658254579?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 13:21","pubTimestamp":1786512091,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","MEDX","RSPH","LNGR","PTH","HART","MDEV","AGNG","LGHT","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911935","title":"板塊普漲之際 十隻量化評分強勁的大盤醫療保健股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911935","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911935?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:27","pubTimestamp":1786462073,"startTime":"0","endTime":"0","summary":"经历 2022-2023年板块低迷后，医疗保健板块在2026年重新积聚上涨动能。Centene Corporation以4.97分接近满分的量化评分位居榜单首位；Corcept Therapeutics、Bright Spring Health Services紧随其后，评分分别为4.93、4.91；Halozyme Therapeutics、Humana跻身前五，均获强烈“买入”评级。即便板块整体处在历史高位，个股之间量化评分分化依旧显著。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303689","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","SG9999017495.SGD","LU0048584097.USD","LU1066051225.USD","LU1934455277.USD","LU1037948897.HKD","VHT","LU1551013425.SGD","BK4534","LU0345770308.USD","IE00BWXC8680.SGD","LU2028103732.USD","LU0708995401.HKD","IE00BFTCPJ56.SGD","GDOC","LU1267930227.SGD","LU0170899867.USD","LU1064131342.USD","BK4613","LU2362541273.HKD","LU0545039389.USD","LU0203347892.USD","LU1732800096.USD","MHIP","LU0198837287.USD","LU0053666078.USD","LU0820561909.HKD","LU0143551892.USD","IE00BJJMRX11.SGD","LU1732799900.SGD","LU0256863811.USD","LU0820562030.AUD","LU0672654240.SGD","LU0203345920.USD","IE000M9KFDE8.USD","LU2954938101.SGD","RXL","LU0094547139.USD","IE00B19Z9Z06.USD","LU0795875086.SGD","LU0477156953.USD","LU0976567544.SGD","FBT","LU0211326839.USD","LU0557290698.USD","LU1983299246.USD","LU0889565916.HKD","IE0004445239.USD","LU2133065610.SGD","LU0342679015.USD","LU2361044865.SGD","LU2552382132.HKD","IE00B19Z3B42.SGD","LGHT","LU2244417387.USD","LU2361044949.HKD","LU2347655156.SGD","SG9999014880.SGD","LU0390134368.USD","BK4196","IHF","IE00BZ1G4Q59.USD","LU0354030511.USD","IE00BJJMRY28.SGD","CNCG","IE00BFSS8Q28.SGD","IE00B1BXHZ80.USD","HUM","BK4588","LU0553294199.USD","IE00B775H168.HKD","LU1791710582.SGD","FHLC","LU0079474960.USD","IE00BSNM7G36.USD","LU0114720955.EUR","SG9999014021.USD","LU0345770993.USD","LU0738911758.USD","LU2089984988.USD","SG9999002232.USD","LU0154245756.USD","LU0708994859.HKD","LU1291159041.SGD","SOLV","LU0432979614.USD","BK4585","BTSG","LU1914381329.SGD","JDOC","LU0097036916.USD","LU1069347547.HKD","IE0002270589.USD","LU0029864427.USD","SGXZ81514606.USD","LU1854103824.USD","IE0034235188.USD","LU2279689827.SGD","LU2111349929.HKD","BK4532","HRTS","IE00B19Z8X17.USD","LU0648000940.SGD","LU1720051108.HKD","LU0661504455.SGD","LU2461242641.AUD","LU1003077747.HKD","LU0162691827.USD","LU0072461881.USD","LU2491050154.USD","IE00B7SZLL34.SGD","LU0122379950.USD","LU0912757837.SGD","BK4154","EKG","LU0965509283.SGD","LU2362540622.SGD","LU2065171402.SGD","UNHW","LU0310799852.SGD","LU1023059063.AUD","LU0251132253.USD","BK4566","IE00B2B36J28.USD","LU0011850046.USD","LU0149725797.USD","LU0320765992.SGD","IE00B1XK9C88.USD","SG9999001176.SGD","LU0965509010.AUD","LU0234572021.USD","XLV","LU1496350502.SGD","LU0052756011.USD","LU1267930490.SGD","LU0158827781.USD","LU1674673691.USD","LU1934455194.USD","LU1506573853.SGD","LU0823416689.USD","IE00B19Z3581.USD","LU0353189763.USD","LU1267930730.SGD","BK4139","LU0130103400.USD","LU2089283258.USD","LU0528227936.USD","IE00B3T34201.USD","IE0004445015.USD","LU1201861165.SGD","LU1261432733.SGD","LU0158827948.USD","LU1699723380.USD","LU2242649171.HKD","LU0566484027.USD","LU2087625088.SGD","IE0005OL40V9.USD","IE00B4JS1V06.HKD","LU1674673428.USD","SG9999014914.USD","IE00B19Z9P08.USD","LU1323610961.USD","LU0320765489.SGD","IE00BN29S564.USD","LU1551013342.USD","LU0787776722.HKD","IE0009355771.USD","LU1983260115.SGD","IXJ","IE00B19Z9505.USD","LU0053671581.USD","LU0949170772.SGD","LU1791710400.SGD","LU0882574055.USD","LU2264538146.SGD","LU2362541513.USD","IE00BJJMRZ35.SGD","LU2065170008.USD","CNC","HALO","LU1084165304.USD","LU1989764748.USD","IE00BFXG1179.USD","IYH","SG9999014898.SGD","LU1074936037.SGD","LU1267930573.SGD","LU1718418525.SGD","LU2357627491.SGD","LU0943347566.SGD","SG9999014906.USD","BK4581","LU2125154935.USD","IE00B7KXQ091.USD","BK4167","LU2236285917.USD","VEEV","LU2468319806.SGD","LU0320765059.SGD","LU1066053197.SGD","LU1201861249.SGD","SG9999018865.SGD","LU0077335932.USD","LU0820561818.USD","LU1670627923.USD","IE00B19Z8W00.USD","LU0211328371.USD","PTH","LU0348723411.USD","LU0689472784.USD","UNH","LU1119994496.HKD","LU1989764664.SGD","PSCH","SG9999013999.USD","LU2271345857.HKD","LU0859254822.USD","LU1559883803.SGD","LU0683600562.USD","FFOX","LU0109394709.USD","LU2023251221.USD","LU0861579265.USD","IE00BKPKM429.USD","BK4198","LU0795875169.SGD","LU2211815571.USD","LU1989771016.USD","LU0238689110.USD","LU0316494557.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","SGXZ99366536.SGD","BK4533","LU1093756168.USD","IE00BJT1NW94.SGD","LU0353189680.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU2089284900.SGD","TMED","IE00BKVL7J92.USD","UNHG","LU2065171311.SGD","FXH","LU1548497426.USD","LU1934455863.HKD","LU0496365809.HKD","LU0130102774.USD","LU0310800379.SGD","LU2361045086.USD","LU0266013472.USD","LU2360032135.SGD","LU1778281490.HKD","LU2552382058.USD","LU0211331839.USD","LU2324357040.USD","LU0477156797.USD","LU1670628061.USD","NBIX","LU2491049909.HKD","LU1057294990.SGD","CORT","LU2999663052.SGD","BK4528","LU1066051811.HKD","SG9999014005.SGD","BK4559","LU0058720904.USD","LU2357305700.SGD","LU0289739699.SGD","LU2125154778.USD","LU0310800965.SGD","LU0965508806.USD","LU2491050071.SGD","LU0109391861.USD","LU0128525929.USD","LU2552382215.SGD","SG9999001176.USD","LU0211327993.USD","LU1854104046.USD","LU0980610538.SGD","LU1066051498.USD","LU0154245673.USD","LU0965509101.SGD","LU1153585028.USD","LU0187121727.USD","TRUH","LU0417517546.SGD","LU1035773651.USD","IE00B894F039.SGD","LU2065169927.USD","IE0002141913.USD","BK4504","IE00BFSS7M15.SGD","LU1093756325.SGD","SGXZ51526630.SGD","LU0070302665.USD","LU2112291526.USD","BK4007","LU0130518102.USD","SG9999014013.SGD","LU0456855351.SGD","LU0128525689.USD","SGXZ31699556.SGD","LU2462591277.SGD","LU0107464264.USD","DVA","LU0648001328.SGD","LU1814569148.SGD","IE00BZ9MQY76.HKD","LU0354030438.USD","LU1988902786.USD","SG9999018857.SGD","LU0130517989.USD","LU1037948541.HKD","LU1720051017.SGD","LU0211326755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658391156","title":"Tango因季度虧損額超出預期而股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2658391156","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658391156?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:19","pubTimestamp":1786461555,"startTime":"0","endTime":"0","summary":"BUZZ-Tango因季度亏损额超出预期而股价下跌8月11日-** 药物研发公司Tango TherapeuticsTNGX.O股价下跌3.3%，报26.75美元** 据LSEG数据显示，该公司报告第二季度每股亏损37美分，而分析师平均预期为每股亏损31美分** TNGX报告称，截至2026年6月30日的三个月内未产生合作收入，原因是与吉利德GILD.O的合作关系及研发活动已终止** 该公司202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4T44814U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BJT1NW94.SGD","SG9999015952.SGD","IDNA","LU1778281490.HKD","IE00B7SZLL34.SGD","BK4139","LU1674673428.USD","IBBQ","CANC","BMED","IE0002270589.USD","LU1037948897.HKD","BK4585","RVMD","LU1066051498.USD","LU0320765992.SGD","LU2324357040.USD","IE00BZ1G4Q59.USD","IE0009355771.USD","LU1674673691.USD","TNGX","LU2468319806.SGD","LU0965508806.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0289739699.SGD","LU0861579265.USD","TBXU","LU2087621335.USD","PTH","IE00B4R5TH58.HKD","LU0234570918.USD","LU0889565916.HKD","BK4588","BIB","LU0114720955.EUR","TMED","GILD","MEDI","BK4583","IE00BJJMRZ35.SGD","LU2089984988.USD","LU1934455277.USD","BK4532","IE00B19Z3581.USD","LU0965509010.AUD","BBH","LU1066053197.SGD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975709","title":"Truist因Revolution Medicines在肺癌研發管線方面的潛力而上調其目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975709","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975709?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 19:42","pubTimestamp":1786448532,"startTime":"0","endTime":"0","summary":"BUZZ-Truist因Revolution Medicines在肺癌研发管线方面的潜力而上调其目标价8月11日-** 券商Truist Securities将Revolution Medicines（RVMD.O）的目标股价从210美元上调至231美元** 维持“买入”评级** 指出elironrasib和zoldonrasib近期已推进至一线非小细胞肺癌（NSCLC）的晚期临床试验，这进一步巩","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S4480SW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","IE0009354923.USD","IDNA","IE00B2B36J28.USD","CANC","LU0320765992.SGD","LU0889565916.HKD","PTH","RVMD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","BBH","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658161961","title":"市值超4800億元的藥企股價漲逾4%: 這款「癌王」突破療法要來中國了","url":"https://stock-news.laohu8.com/highlight/detail?id=2658161961","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658161961?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 12:48","pubTimestamp":1786423687,"startTime":"0","endTime":"0","summary":"8月11日上午，百济神州（ONC.US、06160.HK、688235.SH）A股以及港股股价涨幅超过4%，其中A股市值达到4820亿元。盘面上，公司前一晚与RevolutionMedicines宣布达成临床开发及区域商业化合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608113837721960.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608113837721960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2298322129.HKD","RVMD","IE00BJT1NW94.SGD","BK1588","LU1770034418.SGD","LU1854103824.USD","06160","LU1861214812.USD","LU1548497426.USD","IE00B2B36J28.USD","LU1861219969.SGD","BK4588","LU1251922891.USD","LU0124384867.USD","IE00BFTCPJ56.SGD","KURE","LU1854104046.USD","PTH","IDNA","BK4139","IE0009355771.USD","LU1983260115.SGD","LU1978683503.SGD","LU2357305700.SGD","LU0724618433.USD","IE0009354923.USD","688235","BBH","IE00BJJMRZ35.SGD","LU0348723411.USD","BK4605","LU1720051108.HKD","ON","LU1861215975.USD","LU2360107325.USD","LU0109394709.USD","LU0320765992.SGD","BK1583","IE00BFMHRM44.USD","BK4512","CANC","BK0239","IE0002141913.USD","IE00BZ199S13.USD","BK4585","LU1720051017.SGD","IE00BD6J9T35.USD","LU0889565916.HKD","BK4141","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658965691","title":"港股異動 | 百濟神州(06160)早盤升逾4% 與Revolution Medicines達成臨床合作 將加快RAS賽道開發進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2658965691","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658965691?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 09:42","pubTimestamp":1786412546,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州早盘涨超4%，截至发稿，涨2.72%，报219港元，成交额2.97亿港元。消息面上，8月10日，据百济神州官微消息，公司与Revolution Medicines,Inc.宣布达成一项多方面合作协议。根据协议，双方将开展临床合作，共同评估百济神州部分处于临床阶段的肿瘤候选药物与Revolution Medicines四款临床阶段RAS抑制剂中任意一款或多款药物的联合治疗方案;同时，双方还达成区域授权协议，百济神州获得Revolution Medicines上述候选药物在部分亚洲市场的独家开发及商业化权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RVMD","BK4526","KURE","BK4588","IE00B2B36J28.USD","ONC","BK4585","PTH","IE0002141913.USD","BK1583","LU0320765992.SGD","LU1719994722.HKD","LU1251922891.USD","BK1588","LU1770034418.SGD","LU0228659784.USD","IDNA","BK1161","LU0109394709.USD","LU1969619763.USD","688235","IE0009355771.USD","BK1500","LU0828237510.HKD","BK0239","IE00BJJMRZ35.SGD","BBH","CANC","KCAI","VXUS","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1303224171.USD","IE0009354923.USD","06160","LU0889565916.HKD","LU0588546209.SGD","LU0307460666.USD","LU2328871848.SGD","BK4139","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658500149","title":"中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2658500149","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658500149?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 08:07","pubTimestamp":1786406879,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["601066","BK1100","MDEV","BK1583","AGNG","HART","RSPH","159883","MEDX","LNGR","GDOC","09996","PTH","LGHT","BK1574","BK0276","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658095001","title":"中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095001","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 08:06","pubTimestamp":1786406784,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","LGHT","MEDX","LNGR","HART","GDOC","RSPH","MDEV","IEIH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658950149","title":"百濟神州與Revolution Medicines達成臨床開發及區域商業化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2658950149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658950149?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 07:40","pubTimestamp":1786405224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4526","IDNA","IE0002141913.USD","IE00B4R5TH58.HKD","PTH","LU0889565916.HKD","IE00B2B36J28.USD","BBH","BK4588","IE0009355771.USD","IE0009354923.USD","BK4139","IE00BJJMRZ35.SGD","ONC","LU0109394709.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","BK4585","RVMD","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658950539","title":"百濟神州與Revolution Medicines宣佈合作；甘李藥業宣佈減肥新藥海外BD | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2658950539","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658950539?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 07:01","pubTimestamp":1786402877,"startTime":"0","endTime":"0","summary":"丨2026年8月11日星期二丨NO.1百济神州与RevolutionMedicines宣布达成临床开发及区域商业化合作8月10日，百济神州宣布与全球专注癌症药物研发的生物科技公司RevolutionMedicines达成一项多方面合作协议，涵盖临床联合开发与区域商业化授权两大核心板块，旨在加速RAS驱动型癌症的创新疗法研发与市场落地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608113837029212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608113837029212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["RVMD","IE00BJT1NW94.SGD","BK1588","LU1969619763.USD","LU0228659784.USD","LU1770034418.SGD","06160","IE00B2B36J28.USD","BK4588","LU1251922891.USD","IE00BFTCPJ56.SGD","KURE","PTH","IDNA","BK4139","IE0009355771.USD","BK1515","ONC","IE0009354923.USD","688235","BK4526","BBH","IE00BJJMRZ35.SGD","BD","09939","LU1303224171.USD","LU0109394709.USD","LU0320765992.SGD","BK1583","LU2328871848.SGD","CANC","LU0307460666.USD","BK0239","IE0002141913.USD","LU1719994722.HKD","LU0828237510.HKD","BK4585","BK1161","IE00B4R5TH58.HKD","159938","BK1500","LU0889565916.HKD","BK1574","603087","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189831237","title":"百濟神州獲Revolution Medicines四大資產在選定亞洲市場的獨家授權","url":"https://stock-news.laohu8.com/highlight/detail?id=1189831237","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189831237?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 18:05","pubTimestamp":1786356339,"startTime":"0","endTime":"0","summary":"百济神州（Beone Medicines Ltd.）宣布，已获得Revolution Medicines, Inc.旗下四项核心资产在特定亚洲市场的独家权利。这一战略合作，标志着百济神州在亚洲关键区域的布局进一步深化。\n依据协议，百济神州将独家享有Revolution Medicines这四款创新药物在部分亚洲国家和地区的开发、商业化权益。此举不仅丰富了百济神州的肿瘤产品管线，也为其在亚洲市场的竞争力增添了强劲动力。交易的财务细节尚未披露，但市场分析人士普遍认为，此举对双方而言都是互利共赢的明智选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE0002141913.USD","IE00B2B36J28.USD","PTH","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","RVMD","CANC","688235","IDNA","BK0239","IE0009354923.USD","IE00BFTCPJ56.SGD","BBH","LU0320765992.SGD","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4139","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142470173","title":"百濟神州與Revolution Medicines合作：里程碑付款與分級版税權益","url":"https://stock-news.laohu8.com/highlight/detail?id=1142470173","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142470173?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 18:04","pubTimestamp":1786356295,"startTime":"0","endTime":"0","summary":"百济神州（Beone Medicines Ltd.）与Revolution Medicines, Inc.已达成合作，根据协议，双方将在合作区域内享有获得里程碑付款及分级版税的权利。这一安排标志着两家公司在共同开发与商业化方面迈出了重要一步，为各自带来了潜在的经济收益与战略协同。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","IE0009354923.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","688235","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4139","IDNA","IE00B2B36J28.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","BBH","LU0320765992.SGD","IE0009355771.USD","IE0002141913.USD","BK0239","RVMD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658981293","title":"上海：支持企業研發的創新藥、現代中藥和高端醫療器械全球註冊認證並在當地實現銷售","url":"https://stock-news.laohu8.com/highlight/detail?id=2658981293","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658981293?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 17:08","pubTimestamp":1786352902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IEIH","MEDX","06978","159883","PTH","MDEV","09996","GDOC","BK1583","BK1100","AGNG","IBBQ","LGHT","BK1161","RSPH","HART","BK1574","159992","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658260288","title":"上海市藥品監督管理局批准註冊28項醫療器械產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2658260288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658260288?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 12:05","pubTimestamp":1786334738,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","LGHT","MEDX","LNGR","HART","GDOC","RSPH","MDEV","IEIH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604034","title":"葵花葯業投資成立醫藥公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604034","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658604034?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 12:00","pubTimestamp":1786334411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","GDOC","HART","AGNG","LGHT","MEDX","RSPH","LNGR","PTH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658674572","title":"華東醫藥(000963.SZ)子公司醫療器械獲得歐盟MDR CE認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2658674572","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658674572?lang=zh_tw&edition=fundamental","pubTime":"2026-08-09 16:37","pubTimestamp":1786264666,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华东医药 发布公告，近日，公司英国全资子公司Sinclair Pharma Limited旗下一款全新专利成分的注射用羧甲基壳聚糖溶液KIO015获得欧盟MDR CE认证，取得欧盟市场上市准入资格，系全球首款且目前唯一一款创新型非动物源性壳聚糖医美注射产品。该产品已取得欧盟MDR CE认证，尚未取得国内医疗器械注册证，目前亦未实际形成销售收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0187","LNGR","IEIH","LGHT","PSCM","BK4585","LU2328871848.SGD","AGNG","FSXEmain","BK0132","159883","000963","BK1574","09996","FESXmain","BK1100","MEDX","BK0183","RSPH","BK0209","BK4588","HART","BK1583","MDEV","CE","BK0175","BK4109","BK0188","GDOC","LU1969619763.USD","BK0196","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658674336","title":"浙江推進醫療器械臨床創新成果轉化","url":"https://stock-news.laohu8.com/highlight/detail?id=2658674336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658674336?lang=zh_tw&edition=fundamental","pubTime":"2026-08-09 16:08","pubTimestamp":1786262935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","LGHT","IEIH","MDEV","GDOC","AGNG","PTH","MEDX","HART","LNGR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}